Page last updated: 2024-10-19

niacinamide and Genetic Predisposition

niacinamide has been researched along with Genetic Predisposition in 17 studies

nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.

Research Excerpts

ExcerptRelevanceReference
"Sorafenib currently sets the new standard for advanced hepatocellular carcinoma (HCC)."7.79Genetic predisposition of hand-foot skin reaction after sorafenib therapy in patients with hepatocellular carcinoma. ( Bae, SH; Chung, YH; Kim, BI; Kim, JA; Koh, KC; Lee, D; Lee, HC; Lee, JH; Park, NH; Shim, JH; Shin, ES; Yoon, JH, 2013)
"Sorafenib is a small molecular inhibitor of intracellular tyrosine and serine/threonine protein kinases (VEGFR, PDGFR, CRAF and BRAF), and is thought also to induce autophagy, a chief mechanism influencing tumor growth."6.53Biology, Epidemiology, Clinical Aspects of Hepatocellular Carcinoma and the Role of Sorafenib. ( Grieco, A; Mazzoccoli, G; Miele, L; Oben, J; Vinciguerra, M, 2016)
"Sorafenib currently sets the new standard for advanced hepatocellular carcinoma (HCC)."3.79Genetic predisposition of hand-foot skin reaction after sorafenib therapy in patients with hepatocellular carcinoma. ( Bae, SH; Chung, YH; Kim, BI; Kim, JA; Koh, KC; Lee, D; Lee, HC; Lee, JH; Park, NH; Shim, JH; Shin, ES; Yoon, JH, 2013)
"First degree relatives of type 1 diabetes children attending paediatric clinics in Norway were recruited."2.69[Genetic and immunologic risks for development of type 1 diabetes--experiences from an intervention trial]. ( Dahl-Jørgensen, K; Joner, G; Nicol-Smith, L; Rønningen, KS; Søvik, O; Torjesen, PA; Undlien, DE, 2000)
"Sorafenib is a small molecular inhibitor of intracellular tyrosine and serine/threonine protein kinases (VEGFR, PDGFR, CRAF and BRAF), and is thought also to induce autophagy, a chief mechanism influencing tumor growth."2.53Biology, Epidemiology, Clinical Aspects of Hepatocellular Carcinoma and the Role of Sorafenib. ( Grieco, A; Mazzoccoli, G; Miele, L; Oben, J; Vinciguerra, M, 2016)
"This increase may be part genetic predisposition, and part induction, by excessive exposure to its substrates (particularly nicotinamide) or stress."2.43Parkinson's disease: the first common neurological disease due to auto-intoxication? ( Cartwright, LS; Ramsden, DB; Williams, AC, 2005)
" Pharmacokinetic analysis revealed that oral dosing of t-CUPM resulted in higher blood levels than that of sorafenib throughout the complete time course (48 h)."1.43Inhibition of mutant KrasG12D-initiated murine pancreatic carcinoma growth by a dual c-Raf and soluble epoxide hydrolase inhibitor t-CUPM. ( Hammock, BD; Hwang, SH; Li, H; Liao, J; Liu, JY; Wecksler, AT; Yang, GY; Yang, J; Yang, Y, 2016)
"Thirty-six patients with advanced cancer underwent molecular profiling with NGS with the intent of clinical application of available matched targeted agents."1.43Pilot Study of a Next-Generation Sequencing-Based Targeted Anticancer Therapy in Refractory Solid Tumors at a Korean Institution. ( Kim, HR; Kim, JH; Kim, S; Kwack, K; Lee, MG; Lim, SM; Moon, YW; Park, HS, 2016)
"Malnutrition affects up to one billion people in the world and is a major cause of mortality."1.38ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. ( Camargo, SM; Clevers, H; Fukamizu, A; Hanada, R; Hanada, T; Hashimoto, T; Ishiguro, H; Kuba, K; Lipinski, S; Paolino, M; Penninger, JM; Perlot, T; Rehman, A; Richter, A; Rosenstiel, P; Schreiber, S; Sigl, V; Singer, D; Trichereau, J; Verrey, F; Wild, B, 2012)

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (29.41)29.6817
2010's12 (70.59)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sambeat, A1
Ratajczak, J1
Joffraud, M1
Sanchez-Garcia, JL1
Giner, MP1
Valsesia, A1
Giroud-Gerbetant, J1
Valera-Alberni, M1
Cercillieux, A1
Boutant, M1
Kulkarni, SS1
Moco, S1
Canto, C1
Simmons, K1
Michels, AW1
Mazzoccoli, G1
Miele, L1
Oben, J1
Grieco, A1
Vinciguerra, M1
Liao, J2
Hwang, SH2
Li, H2
Yang, Y1
Yang, J1
Wecksler, AT1
Liu, JY2
Hammock, BD2
Yang, GY2
Park, HS1
Lim, SM1
Kim, S2
Kim, HR1
Kwack, K1
Lee, MG1
Kim, JH1
Moon, YW1
Huang, A1
Ju, HQ1
Liu, K1
Zhan, G1
Liu, D1
Wen, S1
Garcia-Manero, G1
Huang, P1
Hu, Y1
Villanueva, A1
Newell, P1
Hoshida, Y1
Caronia, LM1
Phay, JE1
Shah, MH1
Guo, JM1
Dong, WZ1
Liu, AJ1
Cheng, MH1
Su, DF1
Lee, JH1
Chung, YH1
Kim, JA1
Shim, JH1
Lee, D1
Lee, HC1
Shin, ES1
Yoon, JH1
Kim, BI1
Bae, SH1
Koh, KC1
Park, NH1
Hashimoto, T1
Perlot, T1
Rehman, A1
Trichereau, J1
Ishiguro, H1
Paolino, M1
Sigl, V1
Hanada, T1
Hanada, R1
Lipinski, S1
Wild, B1
Camargo, SM1
Singer, D1
Richter, A1
Kuba, K1
Fukamizu, A1
Schreiber, S1
Clevers, H1
Verrey, F1
Rosenstiel, P1
Penninger, JM1
Williams, AC1
Cartwright, LS1
Ramsden, DB1
Cabrera-Rode, E1
Molina, G1
Arranz, C1
Vera, M1
González, P1
Suárez, R1
Prieto, M1
Padrón, S1
León, R1
Tillan, J1
García, I1
Tiberti, C1
Rodríguez, OM1
Gutiérrez, A1
Fernández, T1
Govea, A1
Hernández, J1
Chiong, D1
Domínguez, E1
Di Mario, U1
Díaz-Díaz, O1
Díaz-Horta, O1
Yan, Z1
Wu, Y2
van Driel, LM1
Smedts, HP1
Helbing, WA1
Isaacs, A1
Lindemans, J1
Uitterlinden, AG1
van Duijn, CM1
de Vries, JH1
Steegers, EA1
Steegers-Theunissen, RP1
Undlien, DE1
Joner, G1
Dahl-Jørgensen, K1
Rønningen, KS1
Nicol-Smith, L1
Torjesen, PA1
Søvik, O1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Evaluation of a Synbiotic Formula in Patient With COVID-19[NCT04730284]20 participants (Anticipated)Interventional2020-08-25Recruiting
An Evaluation of a Synbiotic Formula for Symptom Improvement in Hospitalised Patients With COVID-19 Infection[NCT04581018]50 participants (Anticipated)Interventional2020-08-13Enrolling by invitation
Investigating the Inflammatory Cytokines and Cytokine Storm Among Bangladeshi Patients With COVID-19: a Prospective, Observational Study[NCT04598334]75 participants (Anticipated)Observational2022-07-15Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

6 reviews available for niacinamide and Genetic Predisposition

ArticleYear
Lessons from type 1 diabetes for understanding natural history and prevention of autoimmune disease.
    Rheumatic diseases clinics of North America, 2014, Volume: 40, Issue:4

    Topics: Abatacept; Antibodies, Monoclonal, Humanized; Autoantibodies; Autoimmune Diseases; Diabetes Mellitus

2014
Biology, Epidemiology, Clinical Aspects of Hepatocellular Carcinoma and the Role of Sorafenib.
    Current drug targets, 2016, Volume: 17, Issue:7

    Topics: Animals; Autophagy; Carcinoma, Hepatocellular; Clinical Trials as Topic; Female; Genetic Predisposit

2016
Inherited hepatocellular carcinoma.
    Best practice & research. Clinical gastroenterology, 2010, Volume: 24, Issue:5

    Topics: Algorithms; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Catheter Ablation;

2010
Role of BRAF in thyroid oncogenesis.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Dec-15, Volume: 17, Issue:24

    Topics: Benzenesulfonates; Cell Transformation, Neoplastic; Genetic Predisposition to Disease; Humans; Mutat

2011
Parkinson's disease: the first common neurological disease due to auto-intoxication?
    QJM : monthly journal of the Association of Physicians, 2005, Volume: 98, Issue:3

    Topics: Brain; Environment; Genetic Predisposition to Disease; Humans; Inactivation, Metabolic; Methyltransf

2005
[Relation between cytochrome P450 2D6 and lung cancer susceptibility caused by smoking].
    Wei sheng yan jiu = Journal of hygiene research, 2007, Volume: 36, Issue:1

    Topics: Cytochrome P-450 CYP2D6; Genetic Predisposition to Disease; Humans; Lung Neoplasms; Niacinamide; Nit

2007

Trials

2 trials available for niacinamide and Genetic Predisposition

ArticleYear
Effect of standard nicotinamide in the prevention of type 1 diabetes in first degree relatives of persons with type 1 diabetes.
    Autoimmunity, 2006, Volume: 39, Issue:4

    Topics: Adolescent; Adult; Autoantibodies; Blood Glucose; Child; Child, Preschool; Diabetes Mellitus, Type 1

2006
[Genetic and immunologic risks for development of type 1 diabetes--experiences from an intervention trial].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2000, Sep-30, Volume: 120, Issue:23

    Topics: Adult; Child; Diabetes Mellitus, Type 1; Double-Blind Method; Genetic Markers; Genetic Predispositio

2000

Other Studies

9 other studies available for niacinamide and Genetic Predisposition

ArticleYear
Endogenous nicotinamide riboside metabolism protects against diet-induced liver damage.
    Nature communications, 2019, 09-20, Volume: 10, Issue:1

    Topics: Animals; Blood Glucose; Diet, High-Fat; Disease Models, Animal; DNA Damage; Gene Knockout Techniques

2019
Inhibition of mutant KrasG12D-initiated murine pancreatic carcinoma growth by a dual c-Raf and soluble epoxide hydrolase inhibitor t-CUPM.
    Cancer letters, 2016, Feb-28, Volume: 371, Issue:2

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Benzoates; Carcinoma, Pancreatic Ductal; Cell

2016
Inhibition of Chronic Pancreatitis and Murine Pancreatic Intraepithelial Neoplasia by a Dual Inhibitor of c-RAF and Soluble Epoxide Hydrolase in LSL-KrasG¹²D/Pdx-1-Cre Mice.
    Anticancer research, 2016, Volume: 36, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Anticarcinogenic Agents; Carcinoma in Situ; Ceruletide; Chromatog

2016
Pilot Study of a Next-Generation Sequencing-Based Targeted Anticancer Therapy in Refractory Solid Tumors at a Korean Institution.
    PloS one, 2016, Volume: 11, Issue:4

    Topics: Adult; Afatinib; Aged; Antineoplastic Agents; Asian People; Class I Phosphatidylinositol 3-Kinases;

2016
Metabolic alterations and drug sensitivity of tyrosine kinase inhibitor resistant leukemia cells with a FLT3/ITD mutation.
    Cancer letters, 2016, 07-28, Volume: 377, Issue:2

    Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Deoxyglucose; Dos

2016
Nicotinamide postpones stroke in stroke-prone spontaneously hypertensive rats.
    CNS neuroscience & therapeutics, 2012, Volume: 18, Issue:3

    Topics: Animals; Genetic Predisposition to Disease; Male; Membrane Potential, Mitochondrial; Niacinamide; Ra

2012
Genetic predisposition of hand-foot skin reaction after sorafenib therapy in patients with hepatocellular carcinoma.
    Cancer, 2013, Jan-01, Volume: 119, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Female; Genetic Pr

2013
ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation.
    Nature, 2012, Jul-25, Volume: 487, Issue:7408

    Topics: Angiotensin-Converting Enzyme 2; Animals; Biocatalysis; Colitis; Dextran Sulfate; Diarrhea; Dietary

2012
ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation.
    Nature, 2012, Jul-25, Volume: 487, Issue:7408

    Topics: Angiotensin-Converting Enzyme 2; Animals; Biocatalysis; Colitis; Dextran Sulfate; Diarrhea; Dietary

2012
ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation.
    Nature, 2012, Jul-25, Volume: 487, Issue:7408

    Topics: Angiotensin-Converting Enzyme 2; Animals; Biocatalysis; Colitis; Dextran Sulfate; Diarrhea; Dietary

2012
ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation.
    Nature, 2012, Jul-25, Volume: 487, Issue:7408

    Topics: Angiotensin-Converting Enzyme 2; Animals; Biocatalysis; Colitis; Dextran Sulfate; Diarrhea; Dietary

2012
ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation.
    Nature, 2012, Jul-25, Volume: 487, Issue:7408

    Topics: Angiotensin-Converting Enzyme 2; Animals; Biocatalysis; Colitis; Dextran Sulfate; Diarrhea; Dietary

2012
ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation.
    Nature, 2012, Jul-25, Volume: 487, Issue:7408

    Topics: Angiotensin-Converting Enzyme 2; Animals; Biocatalysis; Colitis; Dextran Sulfate; Diarrhea; Dietary

2012
ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation.
    Nature, 2012, Jul-25, Volume: 487, Issue:7408

    Topics: Angiotensin-Converting Enzyme 2; Animals; Biocatalysis; Colitis; Dextran Sulfate; Diarrhea; Dietary

2012
ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation.
    Nature, 2012, Jul-25, Volume: 487, Issue:7408

    Topics: Angiotensin-Converting Enzyme 2; Animals; Biocatalysis; Colitis; Dextran Sulfate; Diarrhea; Dietary

2012
ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation.
    Nature, 2012, Jul-25, Volume: 487, Issue:7408

    Topics: Angiotensin-Converting Enzyme 2; Animals; Biocatalysis; Colitis; Dextran Sulfate; Diarrhea; Dietary

2012
Eight-fold increased risk for congenital heart defects in children carrying the nicotinamide N-methyltransferase polymorphism and exposed to medicines and low nicotinamide.
    European heart journal, 2008, Volume: 29, Issue:11

    Topics: Adult; Child; Drug-Related Side Effects and Adverse Reactions; Epidemiologic Methods; Female; Geneti

2008